Evidence map›Paper›PMID 27609519›Full record

ArticleThe Journal of biological chemistry2016

Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy.

Hon Chan, C Seth Pearson, Cathleen M Green, Zhong Li, Jing Zhang, Georges Belfort, Alex Shekhtman, Hongmin Li, Marlene Belfort

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Journal of fungi (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Inteins as Drug Targets and Therapeutic Tools.Frontiers in molecular biosciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Small-molecule inhibitors for the Prp8 intein as antifungal agents.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Gold Nanoparticles Augment N-Terminal Cleavage and Splicing Reactions inFrontiers in bioengineering and biotechnology · 2021
    Article
  16. Review
  17. Article
  18. Inhibition of Type IV Secretion Activity and Growth ofFrontiers in cellular and infection microbiology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Hon ChanFrom the Department of Biological Sciences and RNA Institute and.
C Seth PearsonFrom the Department of Biological Sciences and RNA Institute and.
Cathleen M GreenFrom the Department of Biological Sciences and RNA Institute and.
Zhong LiLaboratory of Computational and Structural Biology, Wadsworth Center, New York State Department of Health, Albany, New York 12208, and.
Jing ZhangLaboratory of Computational and Structural Biology, Wadsworth Center, New York State Department of Health, Albany, New York 12208, and.
Georges BelfortHoward P. Isermann Department of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180.
Alex ShekhtmanDepartment of Chemistry, University at Albany, State University of New York, Albany, New York 12222.
Hongmin LiLaboratory of Computational and Structural Biology, Wadsworth Center, New York State Department of Health, Albany, New York 12208, and.
Marlene BelfortFrom the Department of Biological Sciences and RNA Institute and mbelfort@albany.edu.
Rensselaer Polytechnic Institute · USInstitute of Biological, Environmental and Rural Sciences · GBWadsworth Center · USAlbany State University · USUniversity at Albany, State University of New York · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
SELF-SPLICING INTEINS: FUNCTION, EVOLUTION, APPLICATIONR01GM044844 · NIGMS · WADSWORTH CENTER · PI BELFORT, MARLENE · 1990 to 2019
$8.9M
SELF-SPLICING INTRONS IN THE PHAGE T4/E COLI SYSTEMR01GM039422 · NIGMS · WADSWORTH CENTER · PI BELFORT, MARLENE · 1988 to 2019
$5.3M
INTRON DYNAMICS IN BACTERIAR37GM039422 · NIGMS · WADSWORTH CENTER · PI BELFORT, MARLENE · 2001 to 2010
$4.0M
Modular and Project Based Training to Enhance Rigor and Reproducibility in Research for Diverse Biomedical CareersT32GM067545 · NIGMS · RENSSELAER POLYTECHNIC INSTITUTE · PI VASHISHTH, DEEPAK · 2004 to 2020
$3.0M
Real Time (RT) In-cell NMR technology to study protein interactions in live cellsR01GM085006 · NIGMS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI SHEKHTMAN, ALEXANDER · 2010 to 2021
$2.4M
NIGMS NIH HHS P41 GM103393NIGMS NIH HHS P41 GM111244NIGMS NIH HHS R01 GM039422NIGMS NIH HHS R01 GM044844NIGMS NIH HHS R01 GM085006NIGMS NIH HHS R37 GM039422NIGMS NIH HHS T32 GM067545
6 · The paper itself

Abstract

Inteins, self-splicing protein elements, interrupt genes and proteins in many microbes, including the human pathogen Mycobacterium tuberculosis Using conserved catalytic nucleophiles at their N- and C-terminal splice junctions, inteins are able to excise out of precursor polypeptides. The splicing of the intein in the mycobacterial recombinase RecA is specifically inhibited by the widely used cancer therapeutic cisplatin, cis-[Pt(NH

Indexed as

Anti-Infective AgentsBacterial ProteinsCisplatinHumansMycobacterium tuberculosisProtein DomainsRec A RecombinasesAnti-Infective AgentsBacterial ProteinsCisplatinRec A Recombinasesinhibition mechanisminteinmetal ion-protein interactionMycobacterium tuberculosisprotein drug interactionprotein splicing

Identifiers

PMID27609519
PMCPMC5077202
OpenAlexW2515340361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.